Alto Neuroscience Inc (NYSE:ANRO)
$ 28.67 +0.20 (+0.7%) Market Cap: 1.11 Bil Enterprise Value: 873.87 Mil PE Ratio: 0 PB Ratio: 4.13 GF Score: 12/100

Alto Neuroscience Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 06:50 PM GMT
Release Date Price: $20.11 (-2.52%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ANRO.N - Alto Neuroscience Inc
Alto Neuroscience Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 06:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon everybody. My name is Athena Chin. As part of the biotech team here at TD Cowan, welcome to our 46th annual healthcare conference. I'm joined here today with, CEO of Alto Neuroscience, Emme Atkin, who will be providing, a corporate presentation followed by a moderated Q&A, and then I'll open up the floor for any questions. Please take it away.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Great, thank you and thank you for inviting us. This, conference actually brings back, as I was telling attina, brings back memories. This is the first conference
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot